Physician profile
Heather Corbin
NPI 1528363264
$9,825.09
in general payments reported to CMS, 2019-2025
33 companies · $1,856 in 2025
The $1,856 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,486 · 2022: $2,158 · 2023: $2,237 · 2024: $2,089 · 2025: $1,856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,974 · Education: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,974.35 |
| Education | $207.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,052.52 | 2021-2025 | |
| Lilly USA, LLC | $1,033.39 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Pfizer INC. | $906.37 | 2021-2025 | |
| Leo Pharma INC. | $757.35 | 2021-2025 | Adbry, Anzupgo |
| Genzyme Corporation | $708.24 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $667.77 | 2021-2025 | Ilumya, Odomzo, Blu-U |
| Ucb, INC. | $576.92 | 2021-2025 | Bimzelx, Cimzia |
| Janssen Biotech, INC. | $545.95 | 2021-2025 | Tremfya |
| Journey Medical Corporation | $543.74 | 2021-2025 | |
| Galderma Laboratories, L.P. | $429.43 | 2021-2025 | Aklief, Oracea, Epsolay |
| Dermavant Sciences, INC. | $297.74 | 2022-2024 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $246.06 | 2022-2025 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $209.70 | 2022-2025 | Dupixent, Libtayo |
| Amgen INC. | $125.55 | 2021-2025 | Otezla, Otezla |
| Incyte Corporation | $109.17 | 2021-2024 | Opzelura |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $96.87 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.65 | 2022-2023 | Spevigo |
| Organon LLC | $72.81 | 2025 | Vtama |
| Verrica Pharmaceuticals INC. | $54.65 | 2024-2025 | Ycanth |
| Tempus Ai, INC | $47.89 | 2024 | |
| Sandoz INC. | $37.78 | 2023-2024 | Hyrimoz |
| Almirall LLC | $33.14 | 2021-2024 | Klisyri |
| Medimetriks Pharmaceuticals, INC. | $25.40 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.78 | 2023 | Jublia |
| Arcutis Biotherapeutics, INC. | $21.21 | 2025 | Zoryve |
| Biofrontera INC. | $20.60 | 2022 | |
| Mayne Pharma Commercial LLC | $16.96 | 2023 | |
| Botanix Sb INC | $16.45 | 2025 | Sofdra |
| Cipher Pharmaceuticals US LLC | $15.89 | 2025 | Natroba, Spinosad |
| Strata Skin Sciences, INC. | $13.99 | 2024 | Xtrac |
| Sebela Pharmaceuticals INC. | $13.53 | 2023 | Naftin |
| Epi Health, LLC | $13.49 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $13.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Corbin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.